Automated whole animal bio-imaging assay for human cancer dissemination.

A quantitative bio-imaging platform is developed for analysis of human cancer dissemination in a short-term vertebrate xenotransplantation assay. Six days after implantation of cancer cells in zebrafish embryos, automated imaging in 96 well plates coupled to image analysis algorithms quantifies spre...

Full description

Bibliographic Details
Main Authors: Veerander P S Ghotra, Shuning He, Hans de Bont, Wietske van der Ent, Herman P Spaink, Bob van de Water, B Ewa Snaar-Jagalska, Erik H J Danen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22347456/?tool=EBI
id doaj-98586dadc5d548bd80b730a293942246
record_format Article
spelling doaj-98586dadc5d548bd80b730a2939422462021-03-04T01:05:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0172e3128110.1371/journal.pone.0031281Automated whole animal bio-imaging assay for human cancer dissemination.Veerander P S GhotraShuning HeHans de BontWietske van der EntHerman P SpainkBob van de WaterB Ewa Snaar-JagalskaErik H J DanenA quantitative bio-imaging platform is developed for analysis of human cancer dissemination in a short-term vertebrate xenotransplantation assay. Six days after implantation of cancer cells in zebrafish embryos, automated imaging in 96 well plates coupled to image analysis algorithms quantifies spreading throughout the host. Findings in this model correlate with behavior in long-term rodent xenograft models for panels of poorly- versus highly malignant cell lines derived from breast, colorectal, and prostate cancer. In addition, cancer cells with scattered mesenchymal characteristics show higher dissemination capacity than cell types with epithelial appearance. Moreover, RNA interference establishes the metastasis-suppressor role for E-cadherin in this model. This automated quantitative whole animal bio-imaging assay can serve as a first-line in vivo screening step in the anti-cancer drug target discovery pipeline.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22347456/?tool=EBI
collection DOAJ
language English
format Article
sources DOAJ
author Veerander P S Ghotra
Shuning He
Hans de Bont
Wietske van der Ent
Herman P Spaink
Bob van de Water
B Ewa Snaar-Jagalska
Erik H J Danen
spellingShingle Veerander P S Ghotra
Shuning He
Hans de Bont
Wietske van der Ent
Herman P Spaink
Bob van de Water
B Ewa Snaar-Jagalska
Erik H J Danen
Automated whole animal bio-imaging assay for human cancer dissemination.
PLoS ONE
author_facet Veerander P S Ghotra
Shuning He
Hans de Bont
Wietske van der Ent
Herman P Spaink
Bob van de Water
B Ewa Snaar-Jagalska
Erik H J Danen
author_sort Veerander P S Ghotra
title Automated whole animal bio-imaging assay for human cancer dissemination.
title_short Automated whole animal bio-imaging assay for human cancer dissemination.
title_full Automated whole animal bio-imaging assay for human cancer dissemination.
title_fullStr Automated whole animal bio-imaging assay for human cancer dissemination.
title_full_unstemmed Automated whole animal bio-imaging assay for human cancer dissemination.
title_sort automated whole animal bio-imaging assay for human cancer dissemination.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2012-01-01
description A quantitative bio-imaging platform is developed for analysis of human cancer dissemination in a short-term vertebrate xenotransplantation assay. Six days after implantation of cancer cells in zebrafish embryos, automated imaging in 96 well plates coupled to image analysis algorithms quantifies spreading throughout the host. Findings in this model correlate with behavior in long-term rodent xenograft models for panels of poorly- versus highly malignant cell lines derived from breast, colorectal, and prostate cancer. In addition, cancer cells with scattered mesenchymal characteristics show higher dissemination capacity than cell types with epithelial appearance. Moreover, RNA interference establishes the metastasis-suppressor role for E-cadherin in this model. This automated quantitative whole animal bio-imaging assay can serve as a first-line in vivo screening step in the anti-cancer drug target discovery pipeline.
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22347456/?tool=EBI
work_keys_str_mv AT veeranderpsghotra automatedwholeanimalbioimagingassayforhumancancerdissemination
AT shuninghe automatedwholeanimalbioimagingassayforhumancancerdissemination
AT hansdebont automatedwholeanimalbioimagingassayforhumancancerdissemination
AT wietskevanderent automatedwholeanimalbioimagingassayforhumancancerdissemination
AT hermanpspaink automatedwholeanimalbioimagingassayforhumancancerdissemination
AT bobvandewater automatedwholeanimalbioimagingassayforhumancancerdissemination
AT bewasnaarjagalska automatedwholeanimalbioimagingassayforhumancancerdissemination
AT erikhjdanen automatedwholeanimalbioimagingassayforhumancancerdissemination
_version_ 1714809742203813888